-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Neutral on Pliant Therapeuticsto Neutral

Benzinga·03/18/2025 15:53:59
Listen to the news
HC Wainwright & Co. analyst Ed Arce reiterates Pliant Therapeutics (NASDAQ:PLRX) from Neutral to Neutral.